Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sheree E. Chen"'
Autor:
Michael Wang, Preetesh Jain, T Linda Chi, Sheree E Chen, Amy Heimberger, Shiao-Pei Weathers, Lianqing Zheng, Arati V Rao, John M Rossi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Cerebral edema following chimeric antigen receptor (CAR) T-cell therapy can be fatal. ZUMA-2 is a pivotal phase 2, multicenter study evaluating KTE-X19, an autologous anti-CD19 CAR T-cell therapy, in relapsed/refractory mantle cell lymphoma. We descr
Externí odkaz:
https://doaj.org/article/b9c79dd65c64418584175a12ac69626d
Autor:
Shiao Pei Weathers, Sheree E. Chen, T. Linda Chi, Arati V. Rao, Lianqing Zheng, Michael Wang, Preetesh Jain, John M. Rossi, Amy B. Heimberger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Cerebral edema following chimeric antigen receptor (CAR) T-cell therapy can be fatal. ZUMA-2 is a pivotal phase 2, multicenter study evaluating KTE-X19, an autologous anti-CD19 CAR T-cell therapy, in relapsed/refractory mantle cell lymphoma. We descr
Autor:
Brian Primeaux, Huifang Lu, Donna M. Weber, Brandon R. Shank, Bradley Figgins, Sheree E. Chen
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(4)
Introduction Cyclophosphamide is a nitrogen mustard alkylator employed in the treatment of many malignancies and autoimmune disorders. Despite reports of cyclophosphamide hypersensitivity ranging from rash to anaphylaxis, no cases of desensitization
Autor:
Sheree E. Chen, Sattva S. Neelapu, Sandra B. Horowitz, Brandon R. Shank, Bryan Do, Adrienne Sevin
Publikováno v:
Pharmacotherapy. 37(3)
Patients with B-cell hematologic malignancies who progress through first- or second-line chemotherapy have a poor prognosis. Early clinical trials with autologous anti-CD19 chimeric antigen receptor (CAR) T cells have demonstrated promising results f
Autor:
Sheree E. Chen, Makala B. Pace
Publikováno v:
American Journal of Health-System Pharmacy. 69:377-385
Purpose The etiology, diagnosis, staging, and management of malignant pleural mesothelioma (MPM) are reviewed, with an emphasis on clinical trials of newer approaches to first-line, second-line, and adjuvant chemotherapy. Summary In the past decade,
Publikováno v:
Pharmacotherapy. 34(9)
Multiple myeloma is a hematologic malignancy characterized by plasma cell clonal expansion as well as end-organ damage due to increased levels of monoclonal proteins in both the plasma and urine. The clinical syndrome is characterized by hypercalcemi
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 20(2)
Objectives The current standard treatment of glioblastoma includes maximal safe surgical resection, radiation, and temozolomide. Although isotretinoin has been used for maintenance therapy to delay tumor recurrence, this approach has not been proven